Search Result "carnitine palmitoyltransferase inhibitor"
Comparison of (+)- and (-)-Hemipalmitoylcarnitinium as Inhibitors of Hepatic Mitochondrial Carnitine Palmitoyltransferases in Diabetic Rats
Journal: Medicinal Chemistry
Volume: 1 Issue: 5 Year: 2005 Page: 445-453
Author(s): P. S. Savle, N. E. Neptune, Y. Yang, J. H. Rouden, B. L. Kite, E. W. Sugandhi, R. V. Macri, K. Kashfi, R. D. Gandour
The Carnitine Transporter Network: Interactions with Drugs
Journal: Current Chemical Biology
Volume: 4 Issue: 2 Year: 2010 Page: 108-123
Author(s): Cesare Indiveri, Lorena Pochini, Francesca Oppedisano, Annamaria Tonazzi
Involvement of L-Carnitine in Cellular Metabolism: Beyond Acyl-CoA Transport
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 1518-1526
Author(s): S. P. Chapela, N. Kriguer, E. H. Fernandez, C. A. Stella
Mitochondrial Carnitine/Acylcarnitine Translocase: Insights in Structure/ Function Relationships. Basis for Drug Therapy and Side Effects Prediction
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15 Issue: 5 Year: 2015 Page: 396-405
Author(s): Annamaria Tonazzi,Nicola Giangregorio,Lara Console,Cesare Indiveri
Targeting Fatty Acid Metabolism in the Treatments of Obesity and Disorders of CNS Cellular Energy Balance
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2006 Page: 15-25
Author(s): Leslie E. Landree, Eun-Kyoung Kim, Louise D. McCullough, Francis P. Kuhajda, Gabriele V. Ronnett
Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 2 Issue: 2 Year: 2002 Page: 151-165
Author(s): M. C. Sugden, M. J. Holness
Potential Drug Targets and Progress Towards Pharmacologic Inhibition of Hepatic Glucose Production
Journal: Current Medicinal Chemistry
Volume: 10 Issue: 2 Year: 2003 Page: 123-153
Author(s): R. Kurukulasuriya, J. T. Link, D. J. Madar, Z. Pei, S. J. Richards, J. J. Rohde, A. J. Souers, B. G. Szczepankiewicz
Design of Anti-Fasn Molecules as a New Anti-Tumour Modality
Ebook: Frontiers in Drug Design and Discovery
Volume: 5 Year: 2010
Author(s): J. Relat,T. Puig
Doi: 10.2174/978160805203511005010168
Sulfonyl Group-Containing Compounds in the Design of Potential Drugs for the Treatment of Diabetes and Its Complications
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 21 Year: 2012 Page: 3578-3604
Author(s): X. Chen,S. Hussain,S. Parveen,S. Zhang,Y. Yang,C. Zhu
Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 4 Year: 2005 Page: 489-509
Author(s): Alain Grynberg